Concorde Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,120
| Closed | -$956K | – | 166 |
|
|
2021
Q4 | $956K | Buy |
7,120
+36
| +0.5% | +$4.83K | 0.57% | 66 |
|
|
2021
Q3 | $968K | Buy |
+7,084
| New | +$968K | 0.56% | 58 |
|
|
2021
Q2 | – | Sell |
-3,672
| Closed | -$330K | – | 202 |
|
|
2021
Q1 | $330K | Buy |
3,672
+1,420
| +63% | +$128K | 0.19% | 134 |
|
|
2020
Q4 | $208K | Sell |
2,252
-5,388
| -71% | -$498K | 0.12% | 138 |
|
|
2020
Q3 | $787K | Buy |
+7,640
| New | +$787K | 0.45% | 69 |
|